Cancer medicines
Bortezomib
Bortezomib
A proteasome inhibitor used in multiple myeloma and other settings.
Sources checked · Introductory guide
On this page
How it works
It inhibits proteasomes involved in protein processing to kill cancer cells.[2]
Where it is used
Used for multiple myeloma and selected mantle cell lymphoma settings.[1]
Key safety points
Report numbness, pain, weakness, fever or bleeding immediately. Seek prompt advice for a blistering rash.[2]
Questions for your care team
- When should I report numbness, and how might treatment be adjusted?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.